06/07/2024
This systematic review is the first to evaluate the effects of neurofeedback (NF) on impairments and long-term symptoms common in cancer patients. The primary goals were to assess NF's potential to alleviate cancer-related symptoms, describe its effects on brain activity modulation, and identify effective NF systems and protocols for managing cancer-related impairments.
Key findings include:
Positive results from all but one study (in pediatric cancer survivors) indicated that NF therapy could reduce cancer-related symptoms.
A case report showed improvement in symptoms associated with increased qEEG alpha bandwidth.
Various inconsistent NF systems and protocols were noted, and all studies were published in the last five years.
NF training, a noninvasive, drug-free therapy, is widely used in neurology, psychology, and psychiatry, demonstrating effectiveness in conditions like major depressive disorder and anxiety. The review suggests extending these findings to cancer therapy, highlighting NF's potential to teach the brain self-regulation skills and improve self-efficacy. Patients report high acceptance, and the therapy is symptom-specific and easy to learn. Portable biofeedback devices enhance applicability beyond therapeutic settings.
The review confirms NF's potential to alleviate symptoms such as pain, fatigue, low quality of life (QOL), cognitive impairments, sleep disturbances, and psychological strain in cancer patients, although data are scarce. Given the increasing number of cancer patients and survivors, a drug-free intervention with minimal side effects is beneficial.
Future directions include applying NF to different tumor types, addressing methodological weaknesses, and increasing the number of randomized controlled trials (RCTs). There is little international research and unity in self-report instruments, making comparisons challenging. NF appears to alleviate common symptoms like pain and fatigue, but measurements and methodologies are inconsistent.
Cancer patients often suffer from pain, fatigue, cognitive impairment, anxiety, and depression. This review indicates that NF can alleviate these symptoms despite inconsistent measurements and methodological weaknesses. NF offers a drug-free option with few side effects, especially for patients unable to engage in physical activity.
One case report analyzed pre and post qEEG data, showing an increase in alpha bandwidth associated with symptom improvement. More research is needed to standardize measures and understand NF's mechanisms in cancer patients. Comparisons with other drug-free interventions like mindfulness-based stress reduction are lacking but necessary.
Despite the lack of uniform NF systems and protocols, the review shows NF's potential as complementary and alternative medicine (CAM) therapy for cancer patients and survivors. The small number of records and moderate methodological quality are limitations, with few standardized outcome measures and inconsistent NF approaches.
In conclusion, NF shows promise in alleviating cancer-related symptoms, warranting further research. The goal is to improve symptom management and quality of life for cancer survivors. Future studies should include pre- and post-qEEG data, compare NF to other self-regulation approaches, and identify effective NF technologies and protocols. Clinical trials with randomization, double-blinding, and larger sample sizes are needed to advance this field.
Introduction: Neurofeedback (NF) or electroencephalogram (EEG)-Biofeedback is a drug-free form of brain training to directly alter the underlying neural mechanisms of cognition and behavior. It is a technique that measures a subject’s EEG signal, ...